SCHEMBL79345

SCHEMBL79345

C1COC(OC2CCCO2)C1

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4260336 0.94 MEN1 (0.33) NOS2
SCHEMBL30805 0.91 MEN1 (0.33)
SCHEMBL11263233 0.91 MEN1 (0.33)
SCHEMBL28813769 0.91 MEN1 (0.33)
SCHEMBL10644184 0.88 MEN1 (0.33)
Butadiene SCHEMBL616290 0.87
SCHEMBL2571245 0.83
SCHEMBL14230566 0.80
SCHEMBL9785228 0.78 OSBP (0.33)
SCHEMBL16411045 0.78 OSBP (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025053792-A1 COLLECTIVE SYNTHESIS OF PHANTOMOLIN FAMILY THROUGH TOTAL SYNTHESIS OF THE SESQUITERPENE LACTONE MOLEPHANTIN NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2025-03-13 WO claimed
WO-2024145566-A1 PROCESS FOR THE PREPARATION OF DELTA-TOCOTRIENOL PEPTINOVO BIOPHARMA, INC (US) 2024-07-04 WO claimed
WO-2024144812-A1 PROCESS FOR THE PREPARATION OF DELTA-TOCOTRIENOL PEPTINOVO BIOPHARMA INC. (US) 2024-07-04 WO claimed
EP-4393913-A1 PROCESS FOR THE PREPARATION OF DELTA-TOCOTRIENOL Peptinovo Biopharma Inc. (US) 2024-07-03 EP claimed
EP-4161904-A1 INTERMEDIATES AND PROCESSES FOR THE PREPARATION OF TOLVAPTAN AND ITS DERIVATIVES Cambrex Profarmaco Milano S.r.l. (IT) 2023-04-12 EP claimed
CN-111233598-B Method for preparing 4-alkynone/ester compound and application thereof 盐城锦明药业有限公司 2023-04-11 CN claimed
US-20230049294-A1 STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES Atea Pharmaceuticals, Inc. (US) 2023-02-16 US claimed
CN-114316345-B Low-shrinkage long-carbon-chain polyamide elastomer foamed bead as well as preparation method and application thereof 中国科学院化学研究所 2022-09-27 CN claimed
CN-114316345-A Low-shrinkage long-carbon-chain polyamide elastomer foamed bead as well as preparation method and application thereof 中国科学院化学研究所 2022-04-12 CN claimed
WO-2021249877-A1 INTERMEDIATES AND PROCESSES FOR THE PREPARATION OF TOLVAPTAN AND ITS DERIVATIVES CAMBREX PROFARMACO MILANO S.R.L. (IT) 2021-12-16 WO claimed
US-5166301-A Composition dispensing system 3M INNOVATIVE PROPERTIES COMPANY 1992-11-24 US claimed
EP-0374202-A4 COMPOSITION DISPENSING SYSTEM 1991-07-10 EP claimed
EP-0374202-A1 COMPOSITION DISPENSING SYSTEM. POLYMER ENG CORP (US) 1990-06-27 EP claimed
US-4869400-A Composition dispensing system 3M INNOVATIVE PROPERTIES COMPANY 1989-09-26 US claimed
WO-1989008241-A1 COMPOSITION DISPENSING SYSTEM POLYMER ENGINEERING CORPORATION (US) 1989-09-08 WO claimed
EP-0226619-A4 Use of urethane compositions for bumper repair. JACOBS RICHARD 1989-01-24 EP claimed
EP-0226619-A1 Use of urethane compositions for bumper repair. JACOBS RICHARD 1987-07-01 EP claimed
US-4677157-A POLYURETHANE WITH CRYSTALLINE POLYMER PHASE DISTRIBUTED IN AMORPHOUS PHASE POLYMER 3M INNOVATIVE PROPERTIES COMPANY 1987-06-30 US claimed
WO-1986007069-A1 BUMPER REPAIR COMPOSITION JACOBS RICHARD 1986-12-04 WO claimed
US-3993664-A Preparation of prostaglandin intermediates LIBIT LAWRENCE 1976-11-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230049294-A1 STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES NUDT1, PNP, ITPA NOS2 4098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.